Qube Research & Technologies Ltd - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,607,216
+97.1%
200,401
+264.3%
0.00%
+200.0%
Q1 2024$815,248
+1636.5%
55,010
+433.1%
0.00%
Q3 2023$46,947
-94.8%
10,318
-92.0%
0.00%
-100.0%
Q2 2023$908,843
+51.7%
129,097
+31.7%
0.00%0.0%
Q1 2023$598,969
-49.6%
98,031
-47.3%
0.00%
-50.0%
Q4 2022$1,188,252
+353.5%
185,955
+3190.1%
0.01%
+50.0%
Q4 2020$262,000
-31.2%
5,652
-51.2%
0.00%
-20.0%
Q3 2020$381,000
-76.6%
11,586
-80.5%
0.01%
-79.2%
Q2 2020$1,629,000
+45.2%
59,339
+46.4%
0.02%
-31.4%
Q4 2019$1,122,00040,5220.04%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders